The effect of maternal use of telbivudine on neonatal CD4+CD25+ regulatory T cells for the prevention of mother-to-child transmission of hepatitis B virus - 20/03/20
páginas | 9 |
Iconografías | 2 |
Vídeos | 0 |
Otros | 0 |
Highlights |
• | Telbivudine has been proved effective in preventing mother-to-child transmission. |
• | The immunological mechanism of antiviral treatment is explored. |
• | The proportion of regulatory T cells was decreased in neonates of treatment group. |
• | Maternal use of telbivudine may be useful in regulating neonatal immune function. |
Summary |
Antiviral treatment could block mother-to-child transmission (MTCT) of hepatitis B virus (HBV) effectively. We examined whether maternal use of telbivudine (LdT) could decrease the proportion of CD4+CD25+ regulatory T cells and explored the immunological mechanism. A total of 89 pregnant women with HBsAg positive were enrolled, where 30 pregnant women with HBeAg negative (viral load<106 IU/ml) and the other 59 pregnant women with HBeAg positive (viral load≥106 IU/ml) were followed in the study. The women with high viral load were divided to the LdT-treated group where they were prescribed with 600mg LdT daily (29 cases) during the third trimester of pregnancy or to the non-treated group (30 cases) on a voluntary basis. Samples of neonates were taken for analyzing CD4+CD25+ Tregs with flow cytometric techniques. A more significant decrease in the proportion of CD4+CD25+Tregs in neonatal peripheral blood had been observed with maternal use of telbivudine (2.8%±1.1%) than those without any treatment (7.0%±1.6%, P< 0.01). None of the infants in the LdT-treated group were HBsAg positive at 7 months of age. In addition, neonates whose mothers received telbivudine had a significant improvement in cellular immune function, as indicated by the proportion of CD8+ T cells. For HBV carriers with high viral load, maternal use of LdT may be useful in regulating neonatal immune function involved in mother-to-child transmission of hepatitis B virus.
El texto completo de este artículo está disponible en PDF.Keywords : Telbivudine, T-Lymphocytes, Hepatitis B virus, Mother-to-child transmission
Esquema
Vol 44 - N° 2
P. 195-203 - avril 2020 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?